𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Eyelid retraction in dementia with Lewy bodies and Parkinson’s disease

✍ Scribed by Marco Onofrj; Daniela Monaco; Laura Bonanni; Valeria Onofrj; Stefania Bifolchetti; Lamberto Manzoli; Astrid Thomas


Publisher
Springer
Year
2011
Tongue
English
Weight
191 KB
Volume
258
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Treatment of dementia with Lewy bodies a
✍ Werner Poewe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Cognitive decline and dementia affect approximately 30% to 40% of patients with idiopathic Parkinson's disease during the course of their illness. PD-dementia (PDD) and dementia with Lewy bodies (DLB) are second to Alzheimer's disease in causing degenerative dementia in the elderly. The nosological

Cholinergic and other neurotransmitter m
✍ Paul T. Francis; Elaine K. Perry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b

Parkinson's disease and dementia with Le
✍ Irene Hegeman Richard; Michelle Papka; Ana Rubio; Roger Kurlan 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) have clinical features in common and are both characterized neuropathologically by the presence of Lewy bodies (LBs). We conducted a clinicopathological correlation pilot study to better understand whether PD and DLB represent two distinct

Comparison of dementia with Lewy bodies
✍ Enrique Noe; Karen Marder; Karen L. Bell; Diane M. Jacobs; Jennifer J. Manly; Ya 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PD‐d). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PD‐d (n = 15) and AD (n = 16